CN111096452A - Plant probiotic powder or liquid for inhibiting labial melanin and removing peculiar smell and preparation method thereof - Google Patents
Plant probiotic powder or liquid for inhibiting labial melanin and removing peculiar smell and preparation method thereof Download PDFInfo
- Publication number
- CN111096452A CN111096452A CN202010109144.6A CN202010109144A CN111096452A CN 111096452 A CN111096452 A CN 111096452A CN 202010109144 A CN202010109144 A CN 202010109144A CN 111096452 A CN111096452 A CN 111096452A
- Authority
- CN
- China
- Prior art keywords
- parts
- lactobacillus
- oligosaccharide
- powder
- melanin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 title claims abstract description 44
- 239000000843 powder Substances 0.000 title claims abstract description 37
- 239000006041 probiotic Substances 0.000 title claims abstract description 23
- 235000018291 probiotics Nutrition 0.000 title claims abstract description 23
- 230000000529 probiotic effect Effects 0.000 title claims abstract description 20
- 238000002360 preparation method Methods 0.000 title claims abstract description 16
- 230000002401 inhibitory effect Effects 0.000 title claims abstract description 13
- 239000007788 liquid Substances 0.000 title claims abstract description 8
- 241000196324 Embryophyta Species 0.000 claims abstract description 21
- 240000001046 Lactobacillus acidophilus Species 0.000 claims abstract description 19
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 claims abstract description 19
- 241000218588 Lactobacillus rhamnosus Species 0.000 claims abstract description 19
- 229940039695 lactobacillus acidophilus Drugs 0.000 claims abstract description 19
- 240000006024 Lactobacillus plantarum Species 0.000 claims abstract description 18
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims abstract description 18
- 229940072205 lactobacillus plantarum Drugs 0.000 claims abstract description 18
- 229920001202 Inulin Polymers 0.000 claims abstract description 17
- 241000186604 Lactobacillus reuteri Species 0.000 claims abstract description 17
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims abstract description 17
- 229940029339 inulin Drugs 0.000 claims abstract description 17
- 229940001882 lactobacillus reuteri Drugs 0.000 claims abstract description 17
- 241000901050 Bifidobacterium animalis subsp. lactis Species 0.000 claims abstract description 15
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 claims abstract description 15
- 239000004386 Erythritol Substances 0.000 claims abstract description 15
- 240000001717 Vaccinium macrocarpon Species 0.000 claims abstract description 15
- 235000012545 Vaccinium macrocarpon Nutrition 0.000 claims abstract description 15
- 235000002118 Vaccinium oxycoccus Nutrition 0.000 claims abstract description 15
- 229940009289 bifidobacterium lactis Drugs 0.000 claims abstract description 15
- 235000004634 cranberry Nutrition 0.000 claims abstract description 15
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 claims abstract description 15
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 15
- 235000019414 erythritol Nutrition 0.000 claims abstract description 15
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 claims abstract description 15
- 229940009714 erythritol Drugs 0.000 claims abstract description 15
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 claims abstract description 15
- 229940107187 fructooligosaccharide Drugs 0.000 claims abstract description 15
- 239000004480 active ingredient Substances 0.000 claims abstract description 9
- 238000001035 drying Methods 0.000 claims abstract description 8
- 241001134659 Lactobacillus curvatus Species 0.000 claims abstract description 6
- 241000628997 Flos Species 0.000 claims abstract description 3
- 240000000249 Morus alba Species 0.000 claims description 17
- 235000008708 Morus alba Nutrition 0.000 claims description 17
- 240000002853 Nelumbo nucifera Species 0.000 claims description 17
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims description 17
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims description 17
- 235000007516 Chrysanthemum Nutrition 0.000 claims description 16
- 244000124209 Crocus sativus Species 0.000 claims description 16
- 235000015655 Crocus sativus Nutrition 0.000 claims description 16
- 235000013974 saffron Nutrition 0.000 claims description 16
- 239000004248 saffron Substances 0.000 claims description 16
- 241000219357 Cactaceae Species 0.000 claims description 13
- 241000186660 Lactobacillus Species 0.000 claims description 12
- 235000017803 cinnamon Nutrition 0.000 claims description 12
- 239000000706 filtrate Substances 0.000 claims description 12
- 241001313288 Labia Species 0.000 claims description 11
- 229940039696 lactobacillus Drugs 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 238000002156 mixing Methods 0.000 claims description 7
- 241000723353 Chrysanthemum Species 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 5
- 239000002131 composite material Substances 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 238000004806 packaging method and process Methods 0.000 claims description 2
- 238000010298 pulverizing process Methods 0.000 claims description 2
- 244000223760 Cinnamomum zeylanicum Species 0.000 claims 4
- 230000015572 biosynthetic process Effects 0.000 claims 2
- 230000035614 depigmentation Effects 0.000 claims 1
- 230000001105 regulatory effect Effects 0.000 abstract description 9
- 239000002994 raw material Substances 0.000 abstract description 8
- 230000008901 benefit Effects 0.000 abstract description 5
- 230000008021 deposition Effects 0.000 abstract description 5
- 150000001875 compounds Chemical class 0.000 abstract description 3
- 239000005556 hormone Substances 0.000 abstract description 3
- 229940088597 hormone Drugs 0.000 abstract description 3
- 241000594558 Labium Species 0.000 abstract description 2
- 206010046935 Vaginal odour Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 25
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 11
- 239000000047 product Substances 0.000 description 11
- 230000006870 function Effects 0.000 description 10
- 208000024891 symptom Diseases 0.000 description 10
- 210000001035 gastrointestinal tract Anatomy 0.000 description 9
- 241000723347 Cinnamomum Species 0.000 description 8
- 239000008280 blood Substances 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 8
- 239000003814 drug Substances 0.000 description 8
- 230000036541 health Effects 0.000 description 7
- 230000000968 intestinal effect Effects 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- 230000001737 promoting effect Effects 0.000 description 7
- 238000011160 research Methods 0.000 description 7
- 230000000144 pharmacologic effect Effects 0.000 description 6
- 206010061218 Inflammation Diseases 0.000 description 5
- 235000009508 confectionery Nutrition 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 230000004054 inflammatory process Effects 0.000 description 5
- 244000005700 microbiome Species 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- 206010013954 Dysphoria Diseases 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 4
- 230000002159 abnormal effect Effects 0.000 description 4
- 230000000172 allergic effect Effects 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 208000010668 atopic eczema Diseases 0.000 description 4
- 230000003796 beauty Effects 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- GOLXNESZZPUPJE-UHFFFAOYSA-N spiromesifen Chemical compound CC1=CC(C)=CC(C)=C1C(C(O1)=O)=C(OC(=O)CC(C)(C)C)C11CCCC1 GOLXNESZZPUPJE-UHFFFAOYSA-N 0.000 description 4
- 241000193830 Bacillus <bacterium> Species 0.000 description 3
- 208000004926 Bacterial Vaginosis Diseases 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 235000004727 Opuntia ficus indica Nutrition 0.000 description 3
- 240000009297 Opuntia ficus-indica Species 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 239000004744 fabric Substances 0.000 description 3
- 230000008105 immune reaction Effects 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000001850 reproductive effect Effects 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 239000003053 toxin Substances 0.000 description 3
- 231100000765 toxin Toxicity 0.000 description 3
- 108700012359 toxins Proteins 0.000 description 3
- 238000005303 weighing Methods 0.000 description 3
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- 244000037364 Cinnamomum aromaticum Species 0.000 description 2
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 2
- 235000021511 Cinnamomum cassia Nutrition 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 206010024642 Listless Diseases 0.000 description 2
- 208000037093 Menstruation Disturbances Diseases 0.000 description 2
- 206010027339 Menstruation irregular Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 208000037386 Typhoid Diseases 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 230000003042 antagnostic effect Effects 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 210000003756 cervix mucus Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000000378 dietary effect Effects 0.000 description 2
- 230000008034 disappearance Effects 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 230000007160 gastrointestinal dysfunction Effects 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 208000017971 listlessness Diseases 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 244000000010 microbial pathogen Species 0.000 description 2
- 208000037920 primary disease Diseases 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 208000020016 psychiatric disease Diseases 0.000 description 2
- 230000001568 sexual effect Effects 0.000 description 2
- 210000002460 smooth muscle Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 201000008297 typhoid fever Diseases 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000050 Abdominal adhesions Diseases 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 241000193738 Bacillus anthracis Species 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 108010062877 Bacteriocins Proteins 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010054787 Haemorrhoidal haemorrhage Diseases 0.000 description 1
- 238000012404 In vitro experiment Methods 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 208000005647 Mumps Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 208000029082 Pelvic Inflammatory Disease Diseases 0.000 description 1
- 240000008474 Pimenta dioica Species 0.000 description 1
- 235000006990 Pimenta dioica Nutrition 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 235000014443 Pyrus communis Nutrition 0.000 description 1
- 241000133134 Saussurea Species 0.000 description 1
- 241000607762 Shigella flexneri Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 206010046914 Vaginal infection Diseases 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000002052 anaphylactic effect Effects 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 230000001363 autoimmune Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 235000015140 cultured milk Nutrition 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000008482 dysregulation Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 235000021121 fermented vegetables Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- CBCIHIVRDWLAME-UHFFFAOYSA-N hexanitrodiphenylamine Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1NC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O CBCIHIVRDWLAME-UHFFFAOYSA-N 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 238000004898 kneading Methods 0.000 description 1
- 229940068140 lactobacillus bifidus Drugs 0.000 description 1
- 108010042648 lactocin Proteins 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 208000010805 mumps infectious disease Diseases 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 210000004798 organs belonging to the digestive system Anatomy 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001603 reducing effect Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 210000004994 reproductive system Anatomy 0.000 description 1
- 230000001020 rhythmical effect Effects 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 210000001215 vagina Anatomy 0.000 description 1
- 206010046901 vaginal discharge Diseases 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 230000005186 women's health Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Botany (AREA)
- Molecular Biology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
A plant probiotic powder or liquid for inhibiting labium melanin and removing peculiar smell is prepared from flos Chrysanthemi, folium Mori, herba Saussureae Involueratae culture, fructus Pyri Opuntiae Dillenii, stigma croci Sativi, cortex Cinnamomi, inulin, fructo-oligosaccharide, xylo-oligosaccharide, erythritol, cranberry fruit powder, Lactobacillus reuteri LR08, Lactobacillus acidophilus LA85, Lactobacillus plantarum Lp90, Lactobacillus rhamnosus, Bifidobacterium lactis, Lactobacillus curvatus, etc. The preparation method comprises decocting, concentrating, and drying. The invention has the advantages that the raw materials for preparing the active ingredients of the compound preparation have reasonable and scientific compatibility, and can really play the roles of improving melanin deposition, regulating female hormone balance and removing female vaginal odor.
Description
Technical Field
The invention relates to a gynecological health product, in particular to a plant probiotic powder health food with the efficacy of removing peculiar smell of tender labia and a preparation method thereof.
Background
Research has found that most married women are more or less susceptible to certain gynaecological disorders. With the increase of social pressure, working pressure and family pressure, women and friends have a certain difficulty. For example, there is peculiar smell in private parts, more leucorrhea or yellowish leucorrhea, and dull complexion, and melanin in private parts is increased, which causes female dysphoria and anxiety, and seriously affects female life quality. The Chinese medicine treasure house also has good plant medicinal materials for treatment and prevention, and has good effects on clearing metabolic waste in human bodies and gynecological health care. The probiotics is a kind of active microorganisms beneficial to the host, and is a general term for active beneficial microorganisms which are planted in the cavity and reproductive system of the human body and can generate definite health efficacy so as to improve the micro-ecological balance of the host and play the role of anti-allergy. At present, the products with the strongest functions researched in the world are mainly composite active probiotics consisting of various microorganisms, and are widely applied to the fields of bioengineering, industry and agriculture, beauty and skin care and life health. With the development of the times, women have new changes in the pursuit of women's health, and not only have the need of disease treatment, but also have the need of beauty, for example, the need of beauty to make labia dark and black.
Disclosure of Invention
The invention aims to provide the plant probiotic powder for preparing the active ingredients of the medicine, which has reasonable and scientific raw material compatibility and can really improve melanin, adjust the balance of female hormones and remove the peculiar smell of female vaginas.
The invention relates to a plant probiotic powder or liquid for inhibiting labial melanin and removing peculiar smell and a preparation method thereof, and the technical scheme is realized as follows:
a plant probiotic powder or liquid for inhibiting labium melanin and removing peculiar smell is prepared from the following active ingredients in parts by weight:
8-20 parts of chrysanthemum, 12-28 parts of mulberry leaf, 3-12 parts of snow lotus herb culture, 10-18 parts of pome cactus, 1-5 parts of saffron, 4-10 parts of cinnamon, 13-23 parts of inulin, 2-10 parts of fructo-oligosaccharide, 2-10 parts of xylo-oligosaccharide, 2-10 parts of erythritol, 2-10 parts of cranberry fruit powder, LR 082-8 parts of lactobacillus reuteri, LA 852-10 parts of lactobacillus acidophilus, Lp 902-10 parts of lactobacillus plantarum, 2-10 parts of lactobacillus rhamnosus, 2-8 parts of bifidobacterium lactis and 2-10 parts of lactobacillus curvatus.
Furthermore, the plant probiotic powder for inhibiting the peculiar smell of the melanin in the labia is prepared from the following active ingredients in percentage by weight:
10-18 parts of chrysanthemum, 15-25 parts of mulberry leaf, 5-10 parts of snow lotus culture, 10-15 parts of pome cactus, 1-3 parts of saffron, 5-8 parts of cinnamon, 15-20 parts of inulin, 3-8 parts of fructo-oligosaccharide, 3-8 parts of xylo-oligosaccharide, 3-8 parts of erythritol, 3-8 parts of cranberry fruit powder, LR 082-5 parts of lactobacillus reuteri, LA 853-8 parts of lactobacillus acidophilus, Lp 903-8 parts of lactobacillus plantarum, 3-8 parts of lactobacillus rhamnosus, 2-5 parts of bifidobacterium lactis and 3-8 parts of lactobacillus crispus.
Furthermore, the plant probiotic powder for inhibiting the peculiar smell of the melanin in the labia is prepared from the following active ingredients in percentage by weight:
18 parts of chrysanthemum, 20 parts of mulberry leaf, 10 parts of snow lotus culture, 15 parts of pome cactus, 3 parts of saffron, 5 parts of cinnamon, 20 parts of inulin, 6 parts of fructo-oligosaccharide, 4 parts of xylo-oligosaccharide, 6 parts of erythritol, 6 parts of cranberry fruit powder, LR 084 parts of lactobacillus reuteri, LA 856 parts of lactobacillus acidophilus, Lp 908 parts of lactobacillus plantarum, 8 parts of lactobacillus rhamnosus, 5 parts of bifidobacterium lactis and 5 parts of lactobacillus crispus.
Further, the preparation method of the plant probiotic powder for inhibiting the peculiar smell of the melanin in the labia comprises the following steps:
decocting flos Chrysanthemi, folium Mori, herba Saussureae Involueratae culture, fructus Pyri Opuntiae Dillenii, stigma croci Sativi, and cortex Cinnamomi in water, filtering, mixing filtrates, concentrating the filtrate to obtain extract, drying the extract, pulverizing into fine powder, adding inulin, fructo-oligosaccharide, xylo-oligosaccharide, erythritol, cranberry fruit powder, Lactobacillus reuteri LR08, Lactobacillus acidophilus LA85, Lactobacillus plantarum Lp90, Lactobacillus rhamnosus, Bifidobacterium lactis, and Lactobacillus curvatus, mixing well, and packaging.
Further, in the step: the chrysanthemum, the mulberry leaf, the culture of the snow lotus herb, the pome cactus, the saffron and the cinnamon are decocted and extracted by adding water for 2 to 3 times, and each time lasts for 2 to 3 hours.
Further, in the step: concentrating the filtrate to obtain extract with relative density of 1.20-1.25.
Further, in the step: the drying condition of the extract is that the temperature is 70-80 ℃, and the vacuum degree is 0.08-0.1 Mpa.
Plant materials for use in the present invention: the chrysanthemum, the mulberry leaf, the snow lotus herb culture, the pome cactus, the saffron, the cinnamon and the inulin are scientifically matched, and the Chinese medicinal composition has the effects of treating female gynecological inflammation, increasing yellow leucorrhea and irregular menstruation, clearing away heat and toxic materials, promoting qi and blood circulation, removing in-vivo garbage and gradually removing melanin, thereby achieving the effects of beautifying and tendering skin. The instant drink has a very good effect, has a very outstanding effect on regulating qi and blood, can reduce the influence of qi and blood deficiency of women on the human body, enables the human body to be healthier and more refreshing, and enables people to obtain better physical conditions through the drink.
Chrysanthemum: sweet, bitter and slightly cold, entering lung and liver meridians; has the effects of clearing away heat and toxic materials and relieving swelling; pharmacological research shows that the microbial preparation has the effect of resisting pathogenic microorganisms, has a certain inhibition effect on various pathogenic bacteria in a water decoction or water immersion agent test, and has stronger antibacterial effects on staphylococcus aureus, escherichia coli, shigella flexneri and the like.
Mulberry leaf: sweet, bitter and cold in flavor, entering lung and liver meridians; has the effects of dispelling wind and clearing heat; pharmacological research shows that the compound has an antibacterial effect; in vitro experiments of the fresh mulberry leaf decoction have strong antibacterial effects on staphylococcus aureus, beta hemolytic streptococcus, diphtheria bacillus and anthrax bacillus, and also have certain antibacterial effects on escherichia coli, typhoid bacillus, dysentery bacillus and pseudomonas aeruginosa.
Saussurea involucrate culture: preparing a substitute of the snow lotus herb by a plant cell engineering technology, wherein the snow lotus herb is sweet, slightly bitter and warm; has effects in invigorating kidney, supporting yang, regulating menstruation, and stopping bleeding; can be used for treating sexual impotence, menoxenia, metrorrhagia, and leukorrhagia; it is used externally to treat bleeding due to wound. Pharmacological research shows that the medicine has the functions of resisting inflammation and easing pain.
Pear cactus: bitter; cold in nature, entering spleen; the lung meridian; it has effects in clearing away lung heat and relieving cough; cooling blood and removing toxic substance. Can be used for treating hemorrhoidal bleeding; acute mastitis; mumps; carbuncle sore and pyogenic infections; pharmacological research finds that the traditional Chinese medicine composition has an obvious blood sugar reducing effect.
Saffron: sweet and neutral. Enter heart and liver meridians. Has the effects of promoting blood circulation, removing blood stasis, resolving stagnation, treating depression, chest distress, hematemesis, typhoid fever, absentmindedness, amenorrhea, postpartum blood stasis abdominal pain and traumatic injury swelling and pain. Pharmacological research shows that the medicine has the functions of exciting smooth muscle such as small intestine, uterus and the like and promoting rhythmic contraction of the smooth muscle.
Yugui: pungent and sweet with heat entering kidney, spleen and bladder meridians. Has effects of invigorating primordial yang, warming spleen and stomach, removing cold accumulation, and promoting blood circulation, and can be used for treating amenorrhea and abdominal mass. Pharmacological research shows that the Chinese medicinal composition has the effects of tranquilizing, relieving pain, cooling, relieving fever, lowering blood pressure and sterilizing.
The traditional Chinese medicines are reasonable in compatibility, and can be used for resisting bacteria and diminishing inflammation, regulating menstruation and relieving pain, and treating gynecological inflammation, increase of leucorrhea, abnormality and the like.
Inulin is a plant reserve polysaccharide, is a natural water-soluble dietary fiber, and can be utilized by beneficial microorganisms in colon, so as to improve intestinal environment and promote absorption of probiotics.
Probiotic raw materials for use in the present invention: lactobacillus reuteri is a lactobacillus that has been reported to be present in almost all vertebrate and mammalian intestinal tracts. Is a probiotic with the functions of improving allergic constitution, preventing repeated allergic attack and regulating intestinal tract. The lactobacillus reuteri can stimulate the immune system of human body, stimulate Th1 type immune reaction which can regulate anaphylactic immune reaction, balance Th2 type immune reaction caused by anaphylaxis, and achieve the effect of improving allergic constitution. An imbalance in vaginal flora increases the risk of inflammation in the urogenital area of the patient, such as Bacterial Vaginitis (BV), urinary tract infection, pelvic inflammation, etc. BV is the most common vaginal infection in women of childbearing age, with symptoms including bad breath, increased vaginal secretions, and bacterial infections. Regulating intestinal flora balance, and inhibiting proliferation of intestinal undesirable microorganisms.
Lactobacillus acidophilus has antagonistic effect on pathogenic microorganisms. Lactobacillus acidophilus can secrete antibiotic substances (acidophilic lactocin (acidophilolin), acidophilic bacteriocin (acidophilophilin) and lactobacillin (1 aerocidin)), and has antagonistic effect on intestinal pathogenic bacteria.
Lactobacillus acidophilus (A) and Lactobacillus bifidus (B) are mixed to form the leaven. The intake of the milk food containing the two live bacteria is beneficial to digestive organs, and particularly has good nutrition and health care effects on infants with gastrointestinal dysfunction and patients with gastrointestinal dysfunction caused by long-term oral administration of antibiotics, and after the fermented milk containing the two live bacteria is eaten, the normal balance of flora in intestinal tracts can be rapidly restored, and the proliferation of putrefying bacteria is inhibited.
Lactobacillus plantarum (Lactobacillus plantarum) is one of the lactobacilli that are commonly found in fermented vegetables and fruit juices. The lactobacillus plantarum is used as a probiotic flora of the gastrointestinal tract of a human body, and has multiple functions of maintaining the flora balance in the intestinal tract, improving the immunity of the organism, promoting the absorption of nutrient substances and the like.
Lactobacillus rhamnosus (l.rhamnosus), which belongs to the genus lactobacillus, is one of normal flora of human body, has high intestinal adhesion rate and strong colonization ability, and has the functions of efficiently lowering cholesterol, promoting cell division, regulating intestinal flora, preventing and treating diarrhea, removing toxins, preventing dental caries, improving immunity of organism, resisting cancer and other important physiological health care functions. The lactobacillus rhamnosus can tolerate the digestive tract environment of animals, can be planted in human and animal intestinal tracts, and has the effects of regulating intestinal flora, preventing and treating diarrhea, removing toxins, improving the immunity of organisms and the like. The high-purity lactobacillus rhamnosus has good relieving effect on allergic constitution. It can be: 1. balancing and improving gastrointestinal function; 2. enhancing the autoimmune ability of the human body; 3. promoting the growth and the action of bifidobacterium and lactobacillus acidophilus; 4. preventing and helping to treat diarrhea; 5. and discharging the toxin.
The materials are matched, the drug effects complement each other, and the medicine is synchronously conditioned, so that a series of problems caused by discomfort of gastrointestinal tracts, imbalance of intestinal and reproductive flora and irregular menstruation of women can be really solved.
The health food of the present invention is prepared with plant material, and may be also taken by gastrointestinal tract dysfunction patient to reach the health functions of nourishing, beautifying and protecting women.
Compared with the prior art, the invention has the advantages that: 1. the raw materials for preparing the active ingredients of the compound preparation are reasonable and scientific in compatibility, the drug effects complement each other, and a good synergistic effect can be generated, and the prepared product has the effects of clearing heat, removing toxicity, cooling blood, improving the female reproductive flora imbalance function, improving melanin and regulating the balance of female hormone, and solves the series of problems of abnormal odor of pudendum and abnormal yellow and white vaginal discharge disorder caused by vaginal flora imbalance; 2. the preparation technology is advanced and reasonable, and the extraction raw material essence is adopted for concentration, so that higher effective components can be ensured. 3. The production process is simple, and the production cost is reduced.
Detailed Description
In order that the objects, features, advantages and effects achieved by the present invention will be readily apparent and fully understood, specific embodiments of the present invention will be described.
The first embodiment is as follows:
weighing the following raw materials in parts by weight:
10 parts of chrysanthemum, 15 parts of mulberry leaf, 5 parts of snow lotus culture, 10 parts of pome cactus, 1 part of saffron, 5 parts of cinnamon, 15 parts of inulin, 3 parts of fructo-oligosaccharide, 3 parts of xylo-oligosaccharide, 8 parts of erythritol, 8 parts of cranberry fruit powder, LR 082 parts of lactobacillus reuteri, 858 parts of lactobacillus acidophilus LA 858, 903 parts of lactobacillus plantarum Lp, 3 parts of lactobacillus rhamnosus, 2 parts of bifidobacterium lactis and 3 parts of lactobacillus crispus.
The preparation method comprises the following steps:
adding 6 times of water into 10 parts of chrysanthemum, 25 parts of mulberry leaf, 5 parts of snow lotus culture, 10 parts of opuntia ficus-indica, 1 part of saffron and 5 parts of cinnamomum cassia, decocting and extracting for 2 times, filtering by using 100-mesh filter cloth for 3 hours each time, combining filtrates, concentrating the filtrate into an extract with the relative density of 1.20, drying the extract at the temperature of 70-80 ℃ and the vacuum degree of 0.08-0.1 Mpa, kneading into fine powder, adding 15 parts of inulin, 3 parts of fructo-oligosaccharide, 3 parts of xylo-oligosaccharide, 8 parts of erythritol, 8 parts of cranberry fruit powder, LR 082 parts of lactobacillus reuteri, LA 858 parts of lactobacillus acidophilus, 903 parts of lactobacillus plantarum, 3 parts of lactobacillus rhamnosus, 2 parts of bifidobacterium lactis and 3 parts of lactobacillus curvatus, uniformly mixing, and bagging.
Example two:
weighing the following raw materials in parts by weight:
15 parts of chrysanthemum, 20 parts of mulberry leaf, 8 parts of snow lotus culture, 8 parts of pome cactus, 2 parts of saffron, 8 parts of cinnamon, 18 parts of inulin, 8 parts of fructo-oligosaccharide, 5 parts of xylo-oligosaccharide, 5 parts of erythritol, 5 parts of cranberry fruit powder, LR 085 parts of lactobacillus reuteri, 855 parts of lactobacillus acidophilus LA, 905 parts of lactobacillus plantarum, 5 parts of lactobacillus rhamnosus, 3 parts of bifidobacterium lactis and 8 parts of lactobacillus crispus.
The preparation method comprises the following steps:
adding 8 times of water into 15 parts of chrysanthemum, 20 parts of mulberry leaf, 8 parts of snow lotus culture, 8 parts of opuntia ficus-indica, 2 parts of saffron and 8 parts of cinnamomum cassia, decocting and extracting for 3 times, filtering by 150-mesh filter cloth, combining filtrates, concentrating the filtrate into an extract with the relative density of 1.25, drying the extract at the temperature of 70-80 ℃ and the vacuum degree of 0.08-0.1 Mpa, crushing into fine powder, adding 18 parts of inulin, 8 parts of fructo-oligosaccharide, 5 parts of xylo-oligosaccharide, 5 parts of erythritol, 5 parts of cranberry fruit powder, LR 085 parts of lactobacillus reuteri, LA 855 parts of lactobacillus acidophilus, Lp 905 parts of lactobacillus plantarum, 5 parts of lactobacillus rhamnosus, 3 parts of bifidobacterium lactis and 8 parts of lactobacillus crispus, uniformly mixing and bagging.
Example three:
weighing the following raw materials in parts by weight:
18 parts of chrysanthemum, 20 parts of mulberry leaf, 10 parts of snow lotus culture, 15 parts of pome cactus, 3 parts of saffron, 5 parts of cinnamon, 20 parts of inulin, 6 parts of fructo-oligosaccharide, 4 parts of xylo-oligosaccharide, 6 parts of erythritol, 6 parts of cranberry fruit powder, LR 084 parts of lactobacillus reuteri, LA 856 parts of lactobacillus acidophilus, Lp 908 parts of lactobacillus plantarum, 8 parts of lactobacillus rhamnosus, 5 parts of bifidobacterium lactis and 5 parts of lactobacillus crispus.
The preparation method comprises the following steps:
adding 7 times of water into 18 parts of chrysanthemum, 20 parts of mulberry leaves, 10 parts of snow lotus cultures, 15 parts of opuntia ficus-indica, 3 parts of saffron and 5 parts of Pimenta aurantia, decocting and extracting for 2 times, each time for 2.5 hours, filtering by 120-mesh filter cloth, combining the filtrate, concentrating the filtrate into an extract with the relative density of 1.20, drying the extract at the temperature of 70-80 ℃ and the vacuum degree of 0.08-0.1 Mpa, crushing into fine powder, adding 20 parts of inulin, 6 parts of fructo-oligosaccharide, 4 parts of xylo-oligosaccharide, 6 parts of erythritol, 6 parts of cranberry fruit powder, LR 084 parts of lactobacillus reuteri, LA 908 parts of lactobacillus acidophilus, Lp parts of lactobacillus plantarum, 8 parts of lactobacillus rhamnosus, 5 parts of bifidobacterium lactis and 5 parts of lactobacillus leaven, uniformly mixing and bagging.
Test example 1
In order to illustrate the effect of the product on the functions of clearing away heat and toxic material, cooling blood and improving female reproductive flora dysregulation, the product of the invention makes systematic clinical observation on 100 patients with symptoms of damp and hot dampness and heat of females, pudendum odor caused by vaginal flora imbalance, abnormal yellowish leucorrhea, sallow and tarnished complexion, listlessness, dysphoria and the like:
a subject: the disease is diagnosed as the bad smell of pudendum, abnormal yellowish white band, sallow and gloomy complexion, listlessness, dysphoria and malaise symptoms caused by the damp-heat and the heat of lower-part yin and the imbalance of vaginal flora, the age is between 28 and 50 years, and the patients have no serious primary diseases and mental diseases of cardiovascular, liver, kidney and the like.
The scheme is as follows: the product obtained in the third example is taken with boiled water, 5g each time, 3 times a day. During the observation period, the subject needs to maintain reasonable dietary structure and work and rest system, forbid sexual life and forbid other non-observed medicines.
The course of treatment is as follows: for 30 days.
Evaluation criteria:
and (3) curing: disappearance or substantial disappearance of symptoms, signs;
the effect is shown: the symptoms and physical signs are obviously changed;
the method has the following advantages: symptoms and physical signs are all improved;
and (4) invalidation: symptoms and physical signs are not obviously improved.
As a result:
| number of samples | Cure of disease | Show effect | Is effective | Invalidation | Total effective rate |
| 100 | 80 | 11 | 6 | 3 | 97％ |
After 30 days, 80 of 100 subjects taking the product completely disappear the symptoms of damp-heat in lower pudendum, imbalance of pudendum flora, peculiar smell of pudendum, sallow, tarnished, dull and dysphoria complexion, ruddy complexion and smooth mood; symptoms of 11 subjects were significantly improved; the symptoms of 6 subjects are relieved and improved, and the total effective rate reaches 97 percent. The product has no adverse reaction in the clinical observation process, and is safe to take.
Test example two
A subject:
60 volunteered women with labial beauty will be selected as the subject, which is 28-42 years old and has no serious primary diseases such as cardiovascular disease, liver disease, kidney disease and the like and mental diseases. The subject had deposited labial melanin, was darker or darkened.
The test method comprises the following steps: clinical observations
The gynecological doctor examines the natural condition, divides the test subjects into three groups, records the labial color condition of the test subjects in the whole course, observes and compares the color condition. Three groups of subjects were administered with the products obtained in examples one, two and three, respectively, 5g each time, 3 times daily for 30 days. During the observation period, the subject needs to maintain reasonable dietary structure and work and rest system, forbid sexual life and forbid other non-observed medicines.
Evaluation criteria:
the effect is shown: the color of labia is obviously lightened, and the deposition of melanin is obviously improved;
the method has the following advantages: the color of labia is lightened, and the melanin deposition is effectively inhibited;
and (4) invalidation: there was no change in labial color and no change in melanin deposition.
As a result:
| group of | Number of samples | Show effect | Is effective | Invalidation | Total effective rate |
| Example one | 20 | 16 | 2 | 2 | 90％ |
| Example two | 20 | 15 | 2 | 3 | 85％ |
| EXAMPLE III | 20 | 17 | 1 | 2 | 90％ |
As can be seen from the above table, the product obtained in the first example of the present invention is effective in improving the deposition of melanin in the labia, and the effective rate of the product is 90% for the darker or dark color, 85% for the second example, and 90% for the third example.
The above description is only for the purpose of illustrating the preferred embodiments of the present invention and is not to be construed as limiting the invention, and any modifications, equivalents, improvements and the like that fall within the spirit and principle of the present invention are intended to be included therein.
Claims (7)
1. A plant probiotic powder or liquid for inhibiting labial melanin and removing peculiar smell is characterized by being prepared from the following active ingredients in parts by weight:
8-20 parts of chrysanthemum, 12-28 parts of mulberry leaf, 3-12 parts of snow lotus herb culture, 10-18 parts of pome cactus, 1-5 parts of saffron, 4-10 parts of cinnamon, 13-23 parts of inulin, 2-10 parts of fructo-oligosaccharide, 2-10 parts of xylo-oligosaccharide, 2-10 parts of erythritol, 2-10 parts of cranberry fruit powder, LR 082-8 parts of lactobacillus reuteri, LA 852-10 parts of lactobacillus acidophilus, Lp 902-10 parts of lactobacillus plantarum, 2-10 parts of lactobacillus rhamnosus, 2-8 parts of bifidobacterium lactis and 2-10 parts of lactobacillus curvatus.
2. The plant probiotic powder or liquid for inhibiting the melanin formation of the labia and removing the peculiar smell according to claim 1, which is prepared from the following active ingredients in percentage by weight:
10-18 parts of chrysanthemum, 15-25 parts of mulberry leaf, 5-10 parts of snow lotus culture, 10-15 parts of pome cactus, 1-3 parts of saffron, 5-8 parts of cinnamon, 15-20 parts of inulin, 3-8 parts of fructo-oligosaccharide, 3-8 parts of xylo-oligosaccharide, 3-8 parts of erythritol, 3-8 parts of cranberry fruit powder, LR 082-5 parts of lactobacillus reuteri, LA 853-8 parts of lactobacillus acidophilus, Lp 903-8 parts of lactobacillus plantarum, 3-8 parts of lactobacillus rhamnosus, 2-5 parts of bifidobacterium lactis and 3-8 parts of lactobacillus crispus.
3. The plant probiotic powder or liquid for inhibiting the melanin formation of the labia and removing the peculiar smell according to claim 2, which is prepared from the following active ingredients in percentage by weight:
18 parts of chrysanthemum, 20 parts of mulberry leaf, 10 parts of snow lotus culture, 15 parts of pome cactus, 3 parts of saffron, 5 parts of cinnamon, 20 parts of inulin, 6 parts of fructo-oligosaccharide, 4 parts of xylo-oligosaccharide, 6 parts of erythritol, 6 parts of cranberry fruit powder, LR 084 parts of lactobacillus reuteri, LA 856 parts of lactobacillus acidophilus, Lp 908 parts of lactobacillus plantarum, 8 parts of lactobacillus rhamnosus, 5 parts of bifidobacterium lactis and 5 parts of lactobacillus crispus.
4. A method for preparing a plant probiotic powder for inhibiting the depigmentation of the melanin of the labia according to any one of claims 1 to 3, comprising the following steps:
decocting flos Chrysanthemi, folium Mori, herba Saussureae Involueratae culture, fructus Pyri Opuntiae Dillenii, stigma croci Sativi, and cortex Cinnamomi in water, filtering, mixing filtrates, concentrating the filtrate to obtain extract, drying the extract, pulverizing into fine powder, adding inulin, fructo-oligosaccharide, xylo-oligosaccharide, erythritol, cranberry fruit powder, Lactobacillus reuteri LR08, Lactobacillus acidophilus LA85, Lactobacillus plantarum Lp90, Lactobacillus rhamnosus, Bifidobacterium lactis, and Lactobacillus curvatus, mixing well, and packaging.
5. The preparation method of the plant probiotic composite powder according to claim 4, characterized by further comprising the following steps: the chrysanthemum, the mulberry leaf, the culture of the snow lotus herb, the pome cactus, the saffron and the cinnamon are decocted and extracted by adding water for 2 to 3 times, and each time lasts for 2 to 3 hours.
6. The preparation method of the plant probiotic composite powder according to claim 5, characterized by further comprising the following steps: concentrating the filtrate to obtain extract with relative density of 1.20-1.25.
7. The preparation method of the plant probiotic composite powder according to claim 6, wherein the drying condition of the extract is 70-80 ℃ and the vacuum degree is 0.08-0.1 Mpa.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010109144.6A CN111096452A (en) | 2020-02-21 | 2020-02-21 | Plant probiotic powder or liquid for inhibiting labial melanin and removing peculiar smell and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010109144.6A CN111096452A (en) | 2020-02-21 | 2020-02-21 | Plant probiotic powder or liquid for inhibiting labial melanin and removing peculiar smell and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111096452A true CN111096452A (en) | 2020-05-05 |
Family
ID=70427664
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010109144.6A Pending CN111096452A (en) | 2020-02-21 | 2020-02-21 | Plant probiotic powder or liquid for inhibiting labial melanin and removing peculiar smell and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111096452A (en) |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107156852A (en) * | 2017-07-20 | 2017-09-15 | 钟祥亿源生物科技有限公司 | One kind conditioning gynaecological imflammation composition |
| CN107362292A (en) * | 2017-07-19 | 2017-11-21 | 颐和益生（北京）科技有限公司 | It is a kind of that there is the composition for improving female genitourinary system inflammation, preparation method and application |
| CN108157703A (en) * | 2018-02-01 | 2018-06-15 | 河北朗益生物科技有限公司 | A kind of Cranberry inulin probiotics solid beverage and preparation method thereof |
| CN109043273A (en) * | 2018-08-28 | 2018-12-21 | 吉林标普生物科技有限公司 | A kind of functional probiotics solid beverage and preparation method thereof of maintenance women private shield health |
| CN109123295A (en) * | 2018-07-24 | 2019-01-04 | 北京奥维森基因健康科技有限公司 | A kind of probiotics solid beverage and preparation method thereof |
| CN109674826A (en) * | 2019-01-31 | 2019-04-26 | 吉林省知遇科技有限公司 | A kind of probiotic composition for nursing female reproductive system |
-
2020
- 2020-02-21 CN CN202010109144.6A patent/CN111096452A/en active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107362292A (en) * | 2017-07-19 | 2017-11-21 | 颐和益生（北京）科技有限公司 | It is a kind of that there is the composition for improving female genitourinary system inflammation, preparation method and application |
| CN107156852A (en) * | 2017-07-20 | 2017-09-15 | 钟祥亿源生物科技有限公司 | One kind conditioning gynaecological imflammation composition |
| CN108157703A (en) * | 2018-02-01 | 2018-06-15 | 河北朗益生物科技有限公司 | A kind of Cranberry inulin probiotics solid beverage and preparation method thereof |
| CN109123295A (en) * | 2018-07-24 | 2019-01-04 | 北京奥维森基因健康科技有限公司 | A kind of probiotics solid beverage and preparation method thereof |
| CN109043273A (en) * | 2018-08-28 | 2018-12-21 | 吉林标普生物科技有限公司 | A kind of functional probiotics solid beverage and preparation method thereof of maintenance women private shield health |
| CN109674826A (en) * | 2019-01-31 | 2019-04-26 | 吉林省知遇科技有限公司 | A kind of probiotic composition for nursing female reproductive system |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101797304B (en) | Gel for adjusting microecology in vaginas of women | |
| CN110354204B (en) | Composition with eyesight improving effect and preparation and application methods thereof | |
| KR20160037510A (en) | Fermented foods improve bowel function and a method of manufactuing stercoral removal efficacy | |
| CN111345453A (en) | Composite probiotic powder for intestinal tract | |
| CN102178814B (en) | Chinese medicinal composition for treating trichomonas vaginitis and preparation method thereof | |
| CN114921389A (en) | Probiotic composition with female intestinal private part nursing and mammary gland anti-inflammatory effects and application thereof | |
| CN110859871A (en) | Composition for treating prostatitis and preparation method thereof | |
| CN105213941A (en) | A kind of Chinese medicine composition being used for the treatment of infantile diarrhea and preparation method thereof | |
| CN102488814B (en) | Chinese medicinal composition for treating bovine mastitis | |
| CN116350739B (en) | Traditional Chinese medicine composition for treating bacterial vaginitis and preparation method thereof | |
| CN103238757B (en) | Compound feed containing fermented cottonseed meal for chicken for eggs and preparation method thereof | |
| CN113274414A (en) | Probiotics preparation for repairing and maintaining vaginal microecological balance | |
| CN107362292A (en) | It is a kind of that there is the composition for improving female genitourinary system inflammation, preparation method and application | |
| CN109549958B (en) | Composition for treating hormone-dependent dermatitis and preparation method thereof | |
| CN107496767A (en) | A kind of beneficial bacteria ferment for being used to maintain at women secret and preparation method thereof | |
| CN107468999A (en) | A kind of fermentation composition with beauty treatment and eliminating spot function and preparation method thereof | |
| CN106974278A (en) | A kind of prostate nutrient powder and its preparation method and application | |
| CN103239676A (en) | Topical pharmaceutical composition for preventing and treating bacterial vaginosis | |
| CN111096452A (en) | Plant probiotic powder or liquid for inhibiting labial melanin and removing peculiar smell and preparation method thereof | |
| CN107050106A (en) | A kind of lozenge for being used to prevent and treat chronic pharyngitis | |
| CN111955719A (en) | Special medical food for treating inflammatory bowel disease and preparation method thereof | |
| CN106880777A (en) | A kind of Helth-care product with functions of prolonging life and nourishing face and preparation method thereof | |
| CN111184832A (en) | Plant probiotic composition with functions of contracting vagina, lubricating, nourishing and protecting nests and preparation method thereof | |
| CN112089827A (en) | Prebiotic-containing pharmaceutical composition for regulating female vaginal microecological balance, preparation and use thereof | |
| CN111298013A (en) | Formula and preparation method of bacteriostatic gel for lubricating and cleaning vagina |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20200505 |
|
| WD01 | Invention patent application deemed withdrawn after publication |